Augmented Reality for Brain Injury
(PEARL Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method for placing EVDs (a type of tube used to relieve pressure in the brain) using augmented reality technology. The researchers aim to determine if this method is as safe and effective as the traditional image-guided approach. The trial seeks adults who need an EVD due to brain injury or bleeding, especially if scans show brain swelling or shifted brain structures. Participants must be patients at Cooper University Health. As an unphased trial, this study offers patients the chance to contribute to innovative research that could enhance future brain injury treatments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.
What prior data suggests that augmented reality for EVD placement is safe?
Research has shown that using augmented reality (AR) to assist in placing external ventricular drains (EVDs) in the brain holds promise for safety. Previous studies have found that AR-guided EVD placement is accurate and well-tolerated by patients. For instance, one study discovered that AR is more precise than manual EVD placement, potentially reducing errors during the procedure.
Another study used a head-worn AR system to guide EVD placement and reported successful procedures without major safety concerns. Patients handled the AR system well, indicating it is a practical option.
Although few studies exist, current findings encourage those considering joining a trial. Using AR for these procedures appears safe and may offer advantages over traditional methods.12345Why are researchers excited about this trial?
Researchers are excited about using augmented reality (AR) for placing external ventricular drains (EVDs) in brain injury patients because it offers a cutting-edge approach that enhances precision. AR provides surgeons with a real-time, 3D overlay of a patient’s anatomy, potentially reducing errors and improving outcomes compared to traditional methods. On the other hand, the image-guidance technique, while also advanced, relies on pre-operative imaging without real-time updates, which might not offer the same level of adaptability during surgery. By comparing these two methods, researchers hope to find out if AR can set a new standard in neurosurgical procedures, making surgeries safer and more effective.
What evidence suggests that augmented reality is effective for EVD placement?
Research has shown that using augmented reality (AR) to place external ventricular drains (EVDs) is promising. One study found that all AR-guided EVD placements succeeded on the first try, compared to 64% with traditional methods. This suggests that AR might be more accurate than some current techniques. Another study found that AR guidance improved accuracy and quality, especially for beginners. In this trial, participants will be assigned to either the Augmented Reality Assistance arm or the Stealth Image-guided Assistance arm. These findings suggest that AR could be a reliable tool for EVD placement, potentially as effective or even better than traditional image-guided systems.23467
Are You a Good Fit for This Trial?
Adult patients requiring an External Ventricular Drain (EVD) for conditions like spontaneous intracerebral hemorrhage with ventricular involvement or severe traumatic brain injury are eligible. Specific criteria will determine who can participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Procedure
Placement of EVDs using either augmented reality devices or Stealth image-guidance
Follow-up
Participants are monitored for safety and effectiveness after EVD placement
What Are the Treatments Tested in This Trial?
Interventions
- EVD placement - AR assisted
- EVD placement - image-guidance assisted
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cooper Health System
Lead Sponsor